Skip to content

The application of ciprofol combined with dexmedetomidine in postoperative patients in ICU with mechanical ventilation

The application of ciprofol combined with dexmedetomidine in postoperative patients in ICU with mechanical ventilation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092929
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedation of postoperative patients in ICU with mechanical ventilation

Interventions

Ciprofol combined with dexmedetomidine group: Group CD:Group CD: Ciprofol combined with dexmedetomidine
Propofol combined with dexmedetomidine group: Group PD:Group PD: propofol combined with dexmedetomidine

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-70 years old; 2. Admitted to ICU with tube after surgery; 3. ASA Grading II-III; 4.BMI18-30kg/m^2; 5. Estimated tube time is 4-24h; 6. Sign the informed consent form

Exclusion criteria

Exclusion criteria: 1.Allergic to ciprofol or dexmedetomidine; 2. Admitted to ICU after operation with drugs to maintain the blood pressure; 3. Patients after neurosurgery; 4. Patients with psychiatric disorders (schizophrenia, mania) and cognitive dysfunction; 5. History of craniocerebral injury, intracranial hypertension, cerebral aneurysm, cerebrovascular accident and central nervous system disease; 6. Patients with sick sinus syndrome, bradycardia (heart rate less than 50 beats/min), atrioventricular block of 2 degrees or above, and no pacemaker implantation; 7. Severe liver dysfunction (Child-Pugh C), severe renal dysfunction ( dialysis patients before operation) 8. Conditions that other researchers did not consider appropriate for inclusion in the study

Design outcomes

Primary

MeasureTime frame
Incidence of hypotension in ICU patients with sedation;

Secondary

MeasureTime frame
Maintenance dose, supplementary dose and total dose of propofol and ciprofol.;Extubation time after withdrawal;

Countries

China

Contacts

Public ContactLifang Duan

The First Affiliated Hospital of Zhengzhou University

804886172@qq.com+86 371 66862026

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026